JuveStar

Juve (formerly known as JuveStar) is a pre-clinical stage biotechnology company dedicated to developing therapies that target the biological drivers of aging. Founded by leading longevity researcher Eric Verdin and entrepreneur Arlan Fuller, the company translates insights from the Buck Institute for Research on Aging into clinical applications. Juve's research focuses on metabolic health, cellular rejuvenation, and the modulation of pathways that govern healthspan. By addressing the root causes of age-related decline, the company aims to treat a variety of chronic diseases and improve the quality of life for aging populations. Juve is currently advancing its proprietary platform to identify novel small molecule candidates for age-related indications.